Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
about
Drugs under preclinical and clinical study for treatment of acute and chronic lymphoblastic leukemiaOncogenic kinase fusions: an evolving arena with innovative clinical opportunitiesDasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome-positive ALLThe evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults.Treatment of Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia.Minimal Residual Disease in Acute Lymphoblastic Leukemia: How to Recognize and Treat It.Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults.The development of agents targeting the BCR-ABL tyrosine kinase as Philadelphia chromosome-positive acute lymphoblastic leukemia treatment.Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults.Acute lymphoblastic leukemia: a comprehensive review and 2017 updateTargeting BCL-2 and ABL/LYN in Philadelphia chromosome-positive acute lymphoblastic leukemia.Advances in adult acute lymphoblastic leukemia therapy.Phase II study of imatinib-based chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia.Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor.Impact of complete molecular response on survival in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.BCR-ABL translocation as a favorable prognostic factor in elderly patients with acute lymphoblastic leukemia in the era of potent tyrosine kinase inhibitors.An Unsuspected Finding of t(9;22): A Rare Case of Philadelphia Chromosome-Positive B-Lymphoblastic Lymphoma.Hyper-CVAD plus ponatinib versus hyper-CVAD plus dasatinib as frontline therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A propensity score analysis.The presence of Philadelphia chromosome does not confer poor prognosis in adult pre-B acute lymphoblastic leukaemia in the tyrosine kinase inhibitor era - a surveillance, epidemiology, and end results database analysis.Upfront treatment with the first and second-generation tyrosine kinase inhibitors in Ph-positive acute lymphoblastic leukemia.Combination of arsenic trioxide and Dasatinib: a new strategy to treat Philadelphia chromosome-positive acute lymphoblastic leukaemia.Current paradigms in the management of Philadelphia chromosome positive acute lymphoblastic leukemia in adults.10-year complete remission in a Philadelphia chromosome-positive acute lymphoblastic leukemia patient using imatinib without high-intensity chemotherapy or allogeneic stem cell transplantation.Successful reintroduction of blinatumomab in a patient with relapsed/refractory acute lymphoblastic leukemia following grade 4 cytokine release syndrome.Combination of IKZF1 deletion and early molecular response show significant roles on prognostic stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia patients.Second cord blood transplantation and interferon-α maintenance therapy for relapsed Ph+ acute lymphoblastic leukemia with the T315I mutation.Minimal residual disease-based effect and long-term outcome of first-line dasatinib combined with chemotherapy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia.Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL.Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia.Management of older adults with acute lymphoblastic leukemia: challenges & current approaches
P2860
Q26744365-C83F4F39-816A-421D-A91F-BBED78AB952CQ26768158-A54A8564-7211-43B6-B37E-0B938D25C649Q37376595-07EB71ED-5B34-4C54-BB2C-C14D46AE728AQ38674733-CA7C7FD0-D2CC-47B2-A56C-EAB0001509F2Q38734309-F1AB89EC-76B3-4D6C-9291-70E4676F66B9Q38756821-3277F142-156D-451D-8BDC-53E1DF45C9BCQ38777538-86807917-3DC0-4857-8530-7416D12AA903Q38829019-6DDE45E2-FC8D-444C-ADCF-18D301EF498FQ39128765-7EC30EC5-E8A8-48DE-8DAA-6BD334D48602Q39406969-AAC7B08E-E3A7-4526-9ECC-D6658D0DE361Q39434177-E3D64E37-D0B4-489B-8619-972CF3E15308Q39459190-FE6E1CEB-3D29-4975-B856-D42DC2B40169Q40365473-FEA26A47-29AC-4A6B-9FA7-33AB4599C042Q40411475-982A3FE3-EE1B-4322-8E0D-210F9F4DD801Q40731204-CED42782-39D9-4FB2-A1C7-6D4571C859E6Q42336338-C5F1C538-FCB4-4B62-BA4B-CFB3AB98D688Q42717935-E7984617-2599-4AC4-8FB4-C0C4738E93C8Q46196747-38A52939-89D3-4BF2-BBA6-480F754E69B5Q46562404-F8C1CC63-AFB1-4EA7-9C89-1A0F6765C53EQ47104794-DA67EFF2-BCF1-47F7-B8ED-C20013789C5BQ47268493-85B54309-0FFF-40BE-A1A4-42F90B27AA86Q47710825-EEFB5F49-C700-41BD-9771-8B584FE9A7B8Q48213171-BF8209A2-8487-45A3-A872-616C75D2AB8DQ48948724-C76662D6-57FF-4384-8116-0F5D44743201Q50038847-F1196EC1-3708-44E1-BBDF-6FABE51563C1Q50220876-1648D0BB-92F9-4312-91A5-86EEC4315149Q50871700-99AAF16C-63D2-4001-9074-5CE6171A76D7Q52563633-D090A254-68CD-40D8-A2FF-CF753FEC5772Q53838406-F2F92EB5-D9EA-4E4B-9D6F-1580D90E8947Q57301411-27A8575A-0EFA-4E7C-B07B-1692BCAC13EB
P2860
Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Long-term follow-up of a phase ...... acute lymphoblastic leukemia.
@ast
Long-term follow-up of a phase ...... acute lymphoblastic leukemia.
@en
type
label
Long-term follow-up of a phase ...... acute lymphoblastic leukemia.
@ast
Long-term follow-up of a phase ...... acute lymphoblastic leukemia.
@en
prefLabel
Long-term follow-up of a phase ...... acute lymphoblastic leukemia.
@ast
Long-term follow-up of a phase ...... acute lymphoblastic leukemia.
@en
P2093
P2860
P50
P356
P1433
P1476
Long-term follow-up of a phase ...... acute lymphoblastic leukemia.
@en
P2093
Deborah A McCue
Deborah M Thomas
Guillermo Garcia-Manero
Jan A Burger
Michael E Rytting
Partow Kebriaei
Rebecca Garris
Richard Champlin
Susan M O'Brien
Xuelin Huang
P2860
P304
P356
10.1002/CNCR.29646
P407
P50
P577
2015-08-26T00:00:00Z